Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Retatrutide is a 39-amino-acid triple agonist peptide (GLP-1, GIP, and glucagon receptors) that produced 28.7% body weight loss in Phase 3 trials (Lilly Press Release, Dec 2025)
Mechanism: TB-500 TB-500s mechanism is fundamentally different
Common research community cycles run 8 to 12 weeks on, followed by 4 to 6 weeks off
Treatments last approx
This cagrilintide-only table does not include semaglutide
BPC-157/TB-500 BLEND serves as a research model for evaluating peptide interaction dynamics, cellular organization pathways, and the regulation of multiple signaling networks within laboratory settings
US$ 27.35
US$ 27.87
US$ 25.45
US$ 27.85
US$ 23.60
US$ 29.18
